Speaker illustration

Doctor Ali Yari

Danderyd University Hospital, Stockholm (Sweden)

Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment and scores

Thumbnail

Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Acute coronary syndromes, coronary artery disease: treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb